I now think like some said --- even before mTNBC 3
Post# of 153875

But i do think if news rolled out right & especially with a jump to NASDAQ ....could easily roll past that $20 mark
But that 1 thing for me pointing to no buy-out.....is all the other trials. Oncology + those is 1 hell of a ball of yarn to take on as a company.....
PD-L1 has been a focus since 2021.
Look @ all the things since July 2024 data
If im sitting & thinking to sale, i just wouldn't initiate all the other side flak......shall see
Still can't believe 52 months & cold/hot
Wow.....

